MWP
EW icon

Meridian Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Meridian Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-302
Closed -$26K – 474
2021
Q1 		$26K Buy
302
+30
+11% +$2.54K 0.01% 243
2020
Q4 		$25K Sell
272
-29
-10% -$2.41K 0.01% 194
2020
Q3 		$24K Buy
+301
New +$23.5K 0.01% 187

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Meridian Wealth Partners's EW Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 302 shares — an estimated $26K sold.

Meridian Wealth Partners first reported a position in EW in Q3 2020 and held it in 3 quarters. The position peaked at $26K in Q1 2021. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 302 Edwards Lifesciences shares in Q2 2021, an estimated $26K.
  • Meridian Wealth Partners first reported a position in Edwards Lifesciences in Q3 2020 and held it in 3 quarters.
  • Meridian Wealth Partners's Edwards Lifesciences position peaked at $26K in Q1 2021.
  • 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.